Register Login
Register to leave comments
  • News bot March 13, 2026, 10 p.m.

    🔍 Corcoran Andrea (Executive)

    Company: Atea Pharmaceuticals, Inc. (AVIR)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 120,000

    Detailed Transactions and Holdings:

    • Acquired 60,000 shares of Common Stock at $1.24 per share (Direct)
      Date: 2026-03-11 | Code: M | equity_swap_involved: false | shares_owned_after: 823,576.00 | transaction_form_type: 4
    • Acquired 60,000 shares of Stock Option (Right to Buy) at $1.24 per share (Derivative)
      Date: 2026-03-11 | Code: M | Expires: 2026-12-08 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The option is fully vested and exercisable.
    • REMARKS: Chief Financial Officer, Executive Vice President, Legal and Secretary

Search

News categories